SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Oliver & Co who wrote (2281)10/10/1997 9:37:00 PM
From: Izzy   of 6136
 
Anybody read the 1997 Annual Report (I received today)? See page 7 regarding "Product Research and Development. AGPH has a whole bunch of stuff it's working on, particularly 2 potential anti-cancer drugs. AG3340 is an inhibitor of MMP (an enzyme) and AG2034 is an inhibitor of GART (also a tumor cell enzyme). Anybody know the progress in the clinical phase studies? How should I vote my 100 million shares?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext